SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported): July 24, 2001
DISEASE SCIENCES, INC.
---------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 000-27865 13-2640971
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
20283 State Road 7, Suite 400, Boca Raton, Florida 33498
(Address of executive offices and Zip Code)
Registrant's telephone number, including area code: (561)487-3655
AuctionAnything.com, Inc.
-------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Events and Regulation FD Disclosure
On July 24, 2001, pursuant to the terms of an Asset Purchase Agreement
by and between Disease Sciences, Inc., a Delaware corporation formerly known as
AuctionAnything.com, Inc. ("Disease Sciences") and Raymond J. Hotaling, a former
officer and director of Disease Sciences ("Hotaling"), Disease Sciences sold
Hotaling its subsidiary, North Orlando Sports Promotions, Inc., in exchange for
the assumption of all liabilities related to North Orlando and its operations
estimated at approximately $112,000, and which included the forgiveness of
$91,500 in accrued compensation. Included in the sale along with the capital
stock of North Orlando were fixed assets, rights to several domain names and
various contractual rights and obligations. North Orlando, which had been
acquired in March 1999, operated a variety of Internet-related businesses
The foregoing summary of the Asset Purchase Agreement is qualified in
its entirety by reference to the full text of such Agreement, a copy of which is
filed herewith.
On July 16, 2001 pursuant to an Information Statement previously filed
by the registrant with the SEC, the registrant changed its name to Disease
Sciences, Inc.
On July 14, 2001, Messrs. Hotaling and Martin Meads resigned as members
of Disease Sciences' Board of Directors.
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
Exhibit No. Description
10.1 Asset Purchase Agreement
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Disease Sciences, Inc.
Date: July 26, 2001 By: /s/ Dr. Wayne Goldstein
----------------------------
Dr. Wayne Goldstein, President